Get started
Author

Michael D. Parkins

Observed names: M D Parkins, M Parkins, M. D. Parkins, M. Parkins, M.D. Parkins, MICHAEL PARKINS, Michael D Parkins, Michael Parkins, Michael D. Parkins, Parkins, Michael, Parkins, Michael D, Parkins, Michael D.
Observed institutions: Queen's University Belfast, Alberta Health Services, Belfast Health and Social Care Trust, University of Waterloo, University of Alberta, University of Calgary, University of Utah, Foothills Medical Centre, Belfast City Hospital, Department of Biological Sciences, Pediatrics and Genetics, O'Brien Institute for Public Health, McMaster University
ORCID: 0000-0003-3749-7930
Observed ORCID: 0000-0003-3749-7930
OpenAlex ID: A5063583896
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
2008 · Christopher D. Sibley, Michael D. Parkins, et al. · Proceedings of the National Academy of Sciences · 313
Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
2001 · Teresa R. De Kievit, Michael D. Parkins, et al. · Antimicrobial Agents and Chemotherapy · 295
Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation
2001 · Michael D. Parkins, Howard Ceri, et al. · Molecular Microbiology · 263
Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
2008 · Christopher D. Sibley, Kangmin Duan, et al. · PLoS Pathogens · 261
PDF
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
2018 · Michael D. Parkins, Ranjani Somayaji, et al. · Clinical Microbiology Reviews · 253
PDF
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
2007 · Michael D. Parkins, Deana M. Sabuda, et al. · Journal of Antimicrobial Chemotherapy · 229
Incidence, Risk Factors, and Outcomes for Enterococcus spp. Blood Stream Infections: A Population-Based Study
2014 · E.O. Billington, S.H. Phang, et al. · International Journal of Infectious Diseases · 224
PDF
Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
2011 · Christopher D. Sibley, Margot E. Grinwis, et al. · PLoS ONE · 195
PDF
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015 · Michael D. Parkins, R. Andres Floto · Journal of Cystic Fibrosis · 193
PDF
Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
2013 · Matthew L. Workentine, Christopher D. Sibley, et al. · PLoS ONE · 186
PDF
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
2023 · Michael D. Parkins, Bonita E. Lee, et al. · Clinical Microbiology Reviews · 172
PDF
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review
2019 · Ranjani Somayaji, Michael D. Parkins, et al. · Journal of Cystic Fibrosis · 122
PDF
Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
2011 · Michael D. Parkins, Jacqueline C. Rendall, et al. · CHEST Journal · 116
The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review
2008 · Michael D. Parkins, Christopher D. Sibley, et al. · Pediatric Pulmonology · 114
Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection
2009 · M. D. Parkins, D. B. Gregson, et al. · Infection · 105
Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing Strains
2005 · Kevin B. Laupland, Michael D. Parkins, et al. · The Journal of Infectious Diseases · 102
PDF
Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota
2020 · Fiona J. Whelan, Barbara Waddell, et al. · Nature Microbiology · 99
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
2018 · Nicole Acosta, Alya Heirali, et al. · Thorax · 95
A multicenter study investigating SARS-CoV-2 in tertiary-care hospital wastewater. viral burden correlates with increasing hospitalized cases as well as hospital-associated transmissions and outbreaks
2021 · Nicole Acosta, María A. Bautista, et al. · Water Research · 92
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
2016 · Lisa J. Strug, Tanja Gonska, et al. · Human Molecular Genetics · 90
PDF
Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections
2013 · J. T. Ngo, M. D. Parkins, et al. · Infection · 88
Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study
2017 · B. D. Edwards, J. Greysson-Wong, et al. · Journal of Clinical Microbiology · 84
PDF
The genus Prevotella in cystic fibrosis airways
2010 · Tyler R. Field, Christopher D. Sibley, et al. · Anaerobe · 80
A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
2019 · T. E. Woo, R. Lim, et al. · Scientific Reports · 76
PDF
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
2019 · Valerie J Waters, Timothy J Kidd, et al. · Clinical Infectious Diseases · 74
PDF
Works count: 258
Citation count: 6,443
H-index: 42
I10-index: 101
Year
Topic
Type